(603983)"GUANGDONG MARUBI BIOTECHNOLOGY CO., LTD."Announcement on Key Operating Data for Q3 2026
Filed with SSE · Stock code 603983 · · 3 pages · Chinese
Summary by 6ix AI
The report includes details on production, sales, and revenue for various product categories. Additionally, it outlines price changes for major products and raw materials during the same period. The company confirmed that there were no other significant matters affecting its operations in this quarter.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Guangdong Marubi Biotechnology Co., Ltd. on 6ix
Story so far
- (603983)"GUANGDONG MARUBI BIOTECHNOLOGY CO., LTD."Announcement on Use of Idle Raised Funds to Purchase Wealth Management Products
- (603983)"GUANGDONG MARUBI BIOTECHNOLOGY CO., LTD."Announcement on Redemption upon Maturity of Wealth Management Products Purchased with Idle Raised Funds
- (603983)"GUANGDONG MARUBI BIOTECHNOLOGY CO., LTD."Announcement on Return of Raised Funds Used to Temporarily Supplement Working Capital
Earlier from Guangdong Marubi Biotechnology
- (603983)"GUANGDONG MARUBI BIOTECHNOLOGY CO., LTD."Announcement on Use of Idle Raised Funds to Purchase Wealth Management Products
- (603983)"GUANGDONG MARUBI BIOTECHNOLOGY CO., LTD."Announcement on Redemption upon Maturity of Wealth Management Products Purchased with Idle Raised Funds
- (603983)"GUANGDONG MARUBI BIOTECHNOLOGY CO., LTD."Announcement on Return of Raised Funds Used to Temporarily Supplement Working Capital
- Announcement on Attending the 2026 Collective Reception Day for Investors in Guangdong Jurisdiction and Interim Performance Briefing for Listed Companies in the Jurisdiction
- Announcement on Resolutions of the 17th Meeting of the 5th Board of Directors
Follow Guangdong Marubi Biotechnology into a list and get an email when it puts out news.
Follow Guangdong Marubi Biotechnology